• Je něco špatně v tomto záznamu ?

Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials

G. Gargiulo, D. Giacoppo, SS. Jolly, J. Cairns, M. Le May, I. Bernat, E. Romagnoli, SV. Rao, MAH. van Leeuwen, SR. Mehta, OF. Bertrand, GA. Wells, TA. Meijers, GCM. Siontis, G. Esposito, S. Windecker, P. Jüni, M. Valgimigli, Radial Trialists’...

. 2022 ; 146 (18) : 1329-1343. [pub] 20220829

Jazyk angličtina Země Spojené státy americké

Typ dokumentu metaanalýza, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032869

BACKGROUND: In some randomized clinical trials, transradial access (TRA) compared with transfemoral access (TFA) was associated with lower mortality in patients with coronary artery disease undergoing invasive management. We analyzed the effects of TRA versus TFA across multicenter randomized clinical trials and whether these associations are modified by patient or procedural characteristics. METHODS: We performed an individual patient data meta-analysis of multicenter randomized clinical trials comparing TRA with TFA among patients undergoing coronary angiography with or without percutaneous coronary intervention. The primary outcome was all-cause mortality and the co-primary outcome was major bleeding at 30 days. The primary analysis was conducted by 1-stage mixed-effects models on the basis of the intention-to-treat cohort. The effect of access site on mortality and major bleeding was assessed further by multivariable analysis. The relationship among access site, bleeding, and mortality was investigated by natural effect model mediation analysis with multivariable adjustment. RESULTS: A total of 21 600 patients (10 775 TRA, 10 825 TFA) from 7 randomized clinical trials were included. The median age was 63.9 years, 31.9% were women, 95% presented with acute coronary syndrome, and 75.2% underwent percutaneous coronary intervention. All-cause mortality (1.6% versus 2.1%; hazard ratio, 0.77 [95% CI, 0.63-0.95]; P=0.012) and major bleeding (1.5% versus 2.7%; odds ratio, 0.55 [95% CI, 0.45-0.67]; P<0.001) were lower with TRA. Subgroup analyses for mortality showed consistent results, except for baseline hemoglobin level (Pinteraction=0.003), indicating that the benefit of TRA was substantial in patients with moderate or severe anemia, whereas it was not significant in patients with milder or no baseline anemia. After adjustment, TRA remained associated with 24% and 51% relative risk reduction of all-cause mortality and major bleeding, respectively. A mediation analysis showed that the benefit of TRA on mortality was only partially driven by major bleeding prevention and ancillary mechanisms are required to fully explain the causal association. CONCLUSIONS: TRA is associated with lower all-cause mortality and major bleeding at 30 days compared with TFA. The effect on mortality was driven by patients with anemia. The reduction in major bleeding only partially explains the mortality benefit. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42018109664.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032869
003      
CZ-PrNML
005      
20230131151110.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCULATIONAHA.122.061527 $2 doi
035    __
$a (PubMed)36036610
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gargiulo, Giuseppe $u Department of Advanced Biomedical Sciences, University Federico II of Naples, Italy (G.G., G.E.) $1 https://orcid.org/0000000343956742
245    10
$a Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials / $c G. Gargiulo, D. Giacoppo, SS. Jolly, J. Cairns, M. Le May, I. Bernat, E. Romagnoli, SV. Rao, MAH. van Leeuwen, SR. Mehta, OF. Bertrand, GA. Wells, TA. Meijers, GCM. Siontis, G. Esposito, S. Windecker, P. Jüni, M. Valgimigli, Radial Trialists’ Collaboration
520    9_
$a BACKGROUND: In some randomized clinical trials, transradial access (TRA) compared with transfemoral access (TFA) was associated with lower mortality in patients with coronary artery disease undergoing invasive management. We analyzed the effects of TRA versus TFA across multicenter randomized clinical trials and whether these associations are modified by patient or procedural characteristics. METHODS: We performed an individual patient data meta-analysis of multicenter randomized clinical trials comparing TRA with TFA among patients undergoing coronary angiography with or without percutaneous coronary intervention. The primary outcome was all-cause mortality and the co-primary outcome was major bleeding at 30 days. The primary analysis was conducted by 1-stage mixed-effects models on the basis of the intention-to-treat cohort. The effect of access site on mortality and major bleeding was assessed further by multivariable analysis. The relationship among access site, bleeding, and mortality was investigated by natural effect model mediation analysis with multivariable adjustment. RESULTS: A total of 21 600 patients (10 775 TRA, 10 825 TFA) from 7 randomized clinical trials were included. The median age was 63.9 years, 31.9% were women, 95% presented with acute coronary syndrome, and 75.2% underwent percutaneous coronary intervention. All-cause mortality (1.6% versus 2.1%; hazard ratio, 0.77 [95% CI, 0.63-0.95]; P=0.012) and major bleeding (1.5% versus 2.7%; odds ratio, 0.55 [95% CI, 0.45-0.67]; P<0.001) were lower with TRA. Subgroup analyses for mortality showed consistent results, except for baseline hemoglobin level (Pinteraction=0.003), indicating that the benefit of TRA was substantial in patients with moderate or severe anemia, whereas it was not significant in patients with milder or no baseline anemia. After adjustment, TRA remained associated with 24% and 51% relative risk reduction of all-cause mortality and major bleeding, respectively. A mediation analysis showed that the benefit of TRA on mortality was only partially driven by major bleeding prevention and ancillary mechanisms are required to fully explain the causal association. CONCLUSIONS: TRA is associated with lower all-cause mortality and major bleeding at 30 days compared with TFA. The effect on mortality was driven by patients with anemia. The reduction in major bleeding only partially explains the mortality benefit. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42018109664.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a koronární angiografie $x škodlivé účinky $7 D017023
650    _2
$a arteria femoralis $x diagnostické zobrazování $7 D005263
650    _2
$a krvácení $x etiologie $7 D006470
650    _2
$a multicentrické studie jako téma $7 D015337
650    12
$a koronární angioplastika $x škodlivé účinky $7 D062645
650    _2
$a arteria radialis $7 D017534
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
655    _2
$a metaanalýza $7 D017418
655    _2
$a časopisecké články $7 D016428
700    1_
$a Giacoppo, Daniele $u Cardiology Department, Alto Vicentino Hospital, Santorso, Italy (D.G.) $u Cardiovascular Research Institute, Mater Private Hospital, Royal College of Surgeons in Ireland, Dublin (D.G.) $u ISAResearch Center, Deutsches Herzzentrum München, Technisches Universität München, Germany (D.G.) $1 https://orcid.org/0000000190083011
700    1_
$a Jolly, Sanjit S $u Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada (S.S.J., S.R.M.) $1 https://orcid.org/0000000323292504
700    1_
$a Cairns, John $u University of British Columbia, Vancouver, Canada (J.C.) $1 https://orcid.org/0000000188758841
700    1_
$a Le May, Michel $u Department of Medicine, University of Ottawa Heart Institute, Canada (M.L.M., G.A.W.) $1 https://orcid.org/0000000246431709
700    1_
$a Bernat, Ivo $u University Hospital and Faculty of Medicine Pilsen, Charles University, Czech Republic (I.B.) $1 https://orcid.org/0000000331427667
700    1_
$a Romagnoli, Enrico $u Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy (E.R.) $1 https://orcid.org/0000000316117708
700    1_
$a Rao, Sunil V $u The Duke Clinical Research Institute, Durham, NC (S.V.R.) $1 https://orcid.org/0000000329140894
700    1_
$a van Leeuwen, Maarten A H $u Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands (M.A.H.v.L., T.A.M.) $1 https://orcid.org/0000000296093728
700    1_
$a Mehta, Shamir R $u Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada (S.S.J., S.R.M.) $1 https://orcid.org/000000033258949X
700    1_
$a Bertrand, Olivier F $u Quebec Heart and Lung Institute, Quebec City, Canada (O.F.B.)
700    1_
$a Wells, George A $u Department of Medicine, University of Ottawa Heart Institute, Canada (M.L.M., G.A.W.)
700    1_
$a Meijers, Thomas A $u Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands (M.A.H.v.L., T.A.M.) $1 https://orcid.org/0000000242981607
700    1_
$a Siontis, George C M $u Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.) $1 https://orcid.org/0000000321289205
700    1_
$a Esposito, Giovanni $u Department of Advanced Biomedical Sciences, University Federico II of Naples, Italy (G.G., G.E.) $1 https://orcid.org/0000000305657127
700    1_
$a Windecker, Stephan $u Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.) $1 https://orcid.org/0000000326536762
700    1_
$a Jüni, Peter $u Applied Health Research Center, Li Ka Shing Knowledge Institute, St Michael's Hospital, and Department of Medicine, University of Toronto, Canada (P.J.) $1 https://orcid.org/0000000259850670
700    1_
$a Valgimigli, Marco $u Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.) $u Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland (M.V.)
710    2_
$a Radial Trialists’ Collaboration
773    0_
$w MED00001091 $t Circulation $x 1524-4539 $g Roč. 146, č. 18 (2022), s. 1329-1343
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36036610 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151105 $b ABA008
999    __
$a ok $b bmc $g 1891549 $s 1184204
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 146 $c 18 $d 1329-1343 $e 20220829 $i 1524-4539 $m Circulation (New York, N.Y.) $n Circulation (New York) $x MED00001091
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace